N-TERMINAL PORTION OF MOTILIN DETERMINES ITS BIOLOGICAL-ACTIVITY

被引:33
|
作者
POITRAS, P [1 ]
GAGNON, D [1 ]
STPIERRE, S [1 ]
机构
[1] UNIV QUEBEC,INRS SANTE,ST FOY G1V 2M3,QUEBEC,CANADA
关键词
D O I
10.1016/0006-291X(92)91605-P
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to identify the portion of the 22 amino acid sequence of motilin responsible for the biological activity of the peptide. The contraction of rabbit duodenal muscle in vitro was measured when exposed to synthetic fragments of motilin corresponding to various sequences of the C-or N-terminal portions of the molecule. Fragments 2-22 or 3-22 (where the initial amino acids of the N-terminal ending were removed) were more than 1000 times less potent than the native molecule 1-22. Fragment 1-9 (where the last 13 amino acids located at the C-terminal side of motilin were removed) was devoid of any contractile capacity, while synthetic fragments whose C-terminal structure extended beyond the 1-9 motilin sequence maintained almost complete biological activity. N-terminal amino acid sequence 1-9 is therefore an essential determinant of the contractile activity of motilin. © 1992.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 50 条
  • [21] AVIAN MOTILIN - ISOLATION, SEQUENCE, BIOLOGICAL-ACTIVITY AND PHYSIOLOGICAL-ROLE
    DECLERCQ, P
    DEPOORTERE, I
    VERGARA, P
    PEETERS, TL
    GASTROENTEROLOGY, 1995, 108 (04) : A960 - A960
  • [22] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 8-L-ALA-MOTILIN AND 8-D-ALA-MOTILIN
    SHINAGAWA, S
    FUJINO, M
    YAJIMA, H
    SEGAWA, T
    OKUMA, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1978, 26 (03) : 880 - 884
  • [23] The unique N-terminal sequence of the BKCa channel α-subunit determines its modulation by β-subunits
    Lorca, Ramon A.
    Ma, Xiaofeng
    England, Sarah K.
    PLOS ONE, 2017, 12 (07):
  • [24] EVIDENCE FOR BIOLOGICAL-ACTIVITY OF 2 N-TERMINAL FRAGMENTS OF NEUROTENSIN, NEUROTENSIN1-8 AND NEUROTENSIN1-10
    HERNANDEZ, DE
    RICHARDSON, CM
    NEMEROFF, CB
    ORLANDO, RC
    STPIERRE, S
    RIOUX, F
    PRANGE, AJ
    BRAIN RESEARCH, 1984, 301 (01) : 153 - 156
  • [25] Biological activity of GLP-1-analogues with N-terminal modifications
    Siegel, EG
    Gallwitz, B
    Scharf, G
    Mentlein, R
    Morys-Wortmann, C
    Fölsch, UR
    Schrezenmeir, J
    Drescher, K
    Schmidt, WE
    REGULATORY PEPTIDES, 1999, 79 (2-3) : 93 - 102
  • [26] MULLERIAN INHIBITING SUBSTANCE REQUIRES ITS N-TERMINAL DOMAIN FOR MAINTENANCE OF BIOLOGICAL-ACTIVITY, A NOVEL FINDING WITHIN THE TRANSFORMING GROWTH-FACTOR-BETA SUPERFAMILY
    WILSON, CA
    DICLEMENTE, N
    EHRENFELS, C
    PEPINSKY, RB
    JOSSO, N
    VIGIER, B
    CATE, RL
    MOLECULAR ENDOCRINOLOGY, 1993, 7 (02) : 247 - 257
  • [27] Modulatory effects of the N-terminal portion in physalaemin on salivation.
    Abe, K
    Gao, C
    Nan, X
    Ohmori, H
    Nishiura, T
    JOURNAL OF DENTAL RESEARCH, 2000, 79 (05) : 1253 - 1253
  • [28] Regulatory roles for salivation of the N-terminal portion in tachykinins.
    Higa, K
    Nan, X
    Ishibashi, K
    Nishiura, T
    Motokawa, W
    Abe, K
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1344 - 1344
  • [29] SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF DERMORPHIN AND ITS N-TERMINAL SEQUENCES
    SALVADORI, S
    SARTO, G
    TOMATIS, R
    INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1982, 19 (05): : 536 - 542
  • [30] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF N,N'-SULFURYLDIBENZOTRIAZOL
    PURYGIN, PP
    IVANOV, IP
    LALETINA, ZP
    SELEZNEVA, ES
    VAKULKO, OP
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1983, 17 (11): : 1319 - 1321